ST Premium
For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.
Ready to Win Big?
Try Now for Just $1!© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
Investors cannot turn a blind eye to insiders as well as institutional ownership. They need to follow insider trades to determine the direction the stock is likely to take.
About 1.77% of WINT shares are held by financial institutions. PARALLEL ADVISORS, LLC is the top corporate investor, holding 1 shares valued at $1.00. A 0% stake in Windtree Therapeutics, Inc. is owned by the company. owns - shares valued at -, which translates its holding of N/A of the stake in the company.
Among the WINT insiders holding of 0.07% of the stake in company, CENTER LABORATORIES, INC., 10 percent owner, holds the largest shares of 1.24M. LEE'S PHARMACEUTICAL HOLDINGS LTD, 10 percent owner, is the second largest WINT insider with ownership of 827.82K shares. LPH II INVESTMENTS LTD, 10 percent owner, stands third with possession of 827.82K shares of that stake.